F8 and hemophilia: Exceptional activity in hemophilia gene therapy imparts considerable optimism that answers will be identified to progress efforts closer to the ultimate goal of safely and reliably achieving durable and stable FVIII/FIX therapeutic expression able to ameliorate hemophilia phenotype.